Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study by Jabbour, Elias, Dr, Kantarjian, Hagop, Prof, Ravandi, Farhad, Prof, Thomas, Deborah, Prof, Huang, Xuelin, Prof, Faderl, Stefan, Prof, Pemmaraju, Naveen, Prof, Daver, Naval, MD, Garcia-Manero, Guillermo, Prof, Sasaki, Koji, MD, Cortes, Jorge, Prof, Garris, Rebecca, Yin, C Cameron, MD, Khoury, Joseph D, MD, Jorgensen, Jeffrey, Prof, Estrov, Zeev, Prof, Bohannan, Zachary, MA, Konopleva, Marina, MD, Kadia, Tapan, MD, Jain, Nitin, MD, DiNardo, Courtney, MD, Wierda, William, Prof, Jeanis, Vicky, RN, O'Brien, Susan, Prof

Get full text